Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris (NCT07169890) | Clinical Trial Compass
CompletedNot Applicable
Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris
Egypt115 participantsStarted 2025-11-01
Plain-language summary
Acne vulgaris is a common cutaneous inflammatory disorder of the pilosebaceous unit, which runs a chronic course. The condition commonly manifests with papules, pustules, or nodules primarily on the face, although it can also affect the upper arms, trunk, and back. The pathogenesis of acne vulgaris involves the interaction of multiple factors that ultimately lead to the formation of its primary lesion, which is known as "comedo" (see Image. Acne Vulgaris). Although acne vulgaris is commonly observed among adolescents, it is not restricted to this age group and can affect individuals of various ages. The severity of this condition can vary, ranging from a mild presentation with only a few comedones to more severe forms characterized by disfiguring inflammatory manifestations, which can lead to hyperpigmentation, scarring, and adverse psychological effects.
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals aged 18 to 30 years.
* Clinically diagnosed with mild to moderate acne vulgaris.
* Willingness to comply with the study protocol and attend all treatment sessions.
* Medical Clearance: Participants must have medical clearance to participate in this study.
Exclusion Criteria:
* Individuals with severe acne vulgaris or other dermatological conditions affecting the face.
* Current use of systemic acne medications or topical treatments other than the study intervention.
* Known allergy to magnesium or ultrasound gel.
* Pregnant or breastfeeding individuals.
* Severe Comorbidities: Individuals with severe cardiovascular, pulmonary, metabolic, or vascular diseases
* Medication Interference: Individuals using medications known to affect presence of acne.
* Acute Psychological Conditions: Participants with acute psychological conditions that may interfere with participation or assessments.
* Obese patient whose BMI ≥ 30.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.